Data, Peptides, and AI: 2026 Quarter 2 Pharmacy Update with Dr. Nicolette Mathey, PharmD, Dotti CRM
The Bottom Line Pharmacy Podcast: Sykes & Company, P.A. · 2026-06-04 · 25 min
Episode notes
Send us Fan Mail Send us Fan Mail Schedule an Rx Assessment What's really going on with peptides, AI, and the future of independent pharmacy? Turns out, quite a lot. Dr. Nicolette Mathey, PharmD, Founder and CEO of Atrium24 and Dotti CRM, for her quarterly update on the independent pharmacy landscape. We talk about: Headwinds and tailwinds for Q2 of independent pharmacy Upcoming PCAC meeting and what it means for peptide compounding The dangerous peptide gray market How AI is eliminating inefficiencies and transforming pharmacy sales And more! Stay connected with Nicolette, Atrium24, and Dotti: Nicolette’s LinkedIn Atrium24 Website Atrium24 Facebook Atrium24 LinkedIn Stay connected with us: Facebook Twitter LinkedIn Scotty Sykes – CPA, CFP LinkedIn Scotty Sykes – CPA, CFP Twitter Bonnie Bond – CPA LinkedIn Bonnie Bond – CPA Twitter More resources on this topic: Podcast – Driving Independent Pharmacy Profitability in 2026 with Nicolette Mathey, PharmD, CEO of Atrium24 Podcast – A Pharmacists Run for Congress with Dr. Didi Okpareke, PharmD, RPh Podcast – KPIs for the Rapid Growth Pharmacy with Jim Hrncir, R. Ph, Owner of Las Colinas Compounding Pharmacy